TWI430813B - Vesicle composition, and external skin preparations - Google Patents

Vesicle composition, and external skin preparations Download PDF

Info

Publication number
TWI430813B
TWI430813B TW097127163A TW97127163A TWI430813B TW I430813 B TWI430813 B TW I430813B TW 097127163 A TW097127163 A TW 097127163A TW 97127163 A TW97127163 A TW 97127163A TW I430813 B TWI430813 B TW I430813B
Authority
TW
Taiwan
Prior art keywords
component
vesicle composition
vesicle
vesicles
components
Prior art date
Application number
TW097127163A
Other languages
Chinese (zh)
Other versions
TW200922631A (en
Inventor
Yoshikazu Konno
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Publication of TW200922631A publication Critical patent/TW200922631A/en
Application granted granted Critical
Publication of TWI430813B publication Critical patent/TWI430813B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Description

囊泡組成物、及皮膚外用劑Vesicle composition, and skin external preparation

本發明係關於利用溶血磷脂質之囊泡組成物、及由該囊泡分散組成物所形成之皮膚外用劑。The present invention relates to a vesicle composition using a lysophospholipid and an external preparation for skin formed from the vesicle-dispersed composition.

囊泡係具有形成兩性物質之二分子膜結構之封閉小胞,因此特異的結構,可內包有效成分,作為於藥物輸送系統(Drug Deliver System)等之攜帶者而受到矚目。另外,囊泡於角質層中之滯留性高,使有效成分有效率地作用,所以係非常有效地作為皮膚外用劑者。Since the vesicle has a closed cell which forms a two-molecular membrane structure of an amphoteric substance, the specific structure can contain an active ingredient and is attracting attention as a carrier of a drug delivery system (Drug Deliver System) or the like. Further, since the vesicle has high retention in the stratum corneum and the active ingredient acts efficiently, it is very effective as a skin external preparation.

一般存在許多可構成囊泡之兩性物質,尤其由磷脂質所形成之囊泡稱為微脂體(Liposome),對生物體之安全性面上亦進行許多檢討。例如磷脂膽鹼(Phosphatidyl Choline)純度為90%以上,由碘價為0.1以下之磷脂質所構成,粒徑為100~150nm之微脂體(例如參考專利文獻1)等。另外,作為構成囊泡之兩性物質,關於使用合成界面活性劑之囊泡之檢討,進行許多的檢討。使用麥芽糖醇二脂肪酸酯之囊泡製劑之技術(例如參考專利文獻2)或使用多鏈多親水基型界面活性劑之微脂體之技術(例如參考專利文獻3)等。There are many amphoteric substances that can form vesicles. In particular, vesicles formed by phospholipids are called liposome, and many reviews have been made on the safety surface of organisms. For example, phospholipid choline (Phosphatidyl Choline) has a purity of 90% or more, a phospholipid having an iodine value of 0.1 or less, and a liposome having a particle diameter of 100 to 150 nm (for example, refer to Patent Document 1). In addition, as a mixture of vesicles, a review of vesicles using synthetic surfactants has been conducted. A technique of using a vesicle preparation of maltitol difatty acid ester (for example, refer to Patent Document 2) or a technique of using a liposome of a multi-chain polyhydric-based surfactant (for example, refer to Patent Document 3).

另一方面,溶血磷脂質係親水性界面活性劑,使用作為水中油型乳化組成物之乳化劑之技術。例如以特定的比率配合溶血磷脂質及磷脂質及油之透明度高之化粧料(例如參考專利文獻4)。另外,揭示含有磷脂質及規定的陽離子界面活性劑之毛髮用化粧料,可使用溶血體作磷脂質(參考專利文獻5)。On the other hand, a lysophospholipid-based hydrophilic surfactant is a technique using an emulsifier as an oil-in-water emulsion composition. For example, a cosmetic having a high transparency of a lysophospholipid, a phospholipid, and an oil is blended at a specific ratio (for example, refer to Patent Document 4). Further, a cosmetic for hair containing a phospholipid and a predetermined cationic surfactant is disclosed, and a lysosome can be used as a phospholipid (refer to Patent Document 5).

另外,液狀之高級醇或液狀之高級脂肪酸係使用作為使乳化粒子更微細化等之助乳化劑之技術(例如參考專利文獻6)。In addition, a liquid-based higher alcohol or a liquid higher fatty acid is used as a co-emulsifier which makes the emulsified particles finer (for example, refer to Patent Document 6).

另外,化粧料等之皮膚外用劑係作為賦予各種美容效果或附加價值之目的而配合電解質。例如胺基酸、dl-吡咯烷酮羧酸鈉、乳酸鈉或作為美白成分之抗壞血酸衍生物等之有機鹽、或氯化鈉等之無機鹽等。In addition, an external preparation for skin such as a cosmetic is blended with an electrolyte for the purpose of imparting various cosmetic effects or added value. For example, an amino acid, an organic salt such as sodium dl-pyrrolidonecarboxylate, sodium lactate or an ascorbic acid derivative as a whitening component, or an inorganic salt such as sodium chloride.

[專利文獻1]特開2006-124378號公報[Patent Document 1] JP-A-2006-124378

[專利文獻2]特開平06-157296號公報[Patent Document 2] Japanese Patent Publication No. 06-157296

[專利文獻3]特開2006-290894號公報[Patent Document 3] JP-A-2006-290894

[專利文獻4]特開2001-302433號公報[Patent Document 4] JP-A-2001-302433

[專利文獻5]特開2006-193461號公報[Patent Document 5] JP-A-2006-193461

[專利文獻6]特開2004-277341號公報[Patent Document 6] JP-A-2004-277341

關於如此囊泡製劑之技術雖有許多,但仍有如下之問題點。例如專利文獻1之技術,雖然使用感優異,但經時變臭,或受限於安定製劑之pH範圍,應用於化粧料等之皮膚外用劑受到限制。專利文獻2之技術,與微脂體相比較,對肌膚的滲透感低,感到發黏。另外,專利文獻3之技術係利用胺基酸系界面活性劑,雖可以簡便的方法得到囊泡,但關於其保存安定性並不充份。另外,於賦予保濕效果或美白效果等目的等所配合之電解質存在下,實際情況係如此技術破壞囊泡特有的二分子膜結構,於高溫之保存性不足。Although there are many techniques for such vesicle preparations, the following problems remain. For example, in the technique of Patent Document 1, although the feeling of use is excellent, it is odor-prone over time, or is limited by the pH range of the customizing agent, and the skin external preparation applied to cosmetics or the like is limited. According to the technique of Patent Document 2, compared with the liposome, the penetration to the skin is low and it feels sticky. Further, the technique of Patent Document 3 utilizes an amino acid-based surfactant, and although vesicles can be obtained by a simple method, the preservation stability is not sufficient. Further, in the presence of an electrolyte to which a moisturizing effect, a whitening effect, or the like is imparted, the actual situation is such that the technique destroys the bimolecular film structure unique to the vesicle, and the preservation property at high temperature is insufficient.

因此要求開發與上述技術相異之如微脂體般使用感優異,而且形成保存安定性優異之囊泡之皮膚外用劑,進而要求開發即使於電解質存在下,仍可形成囊泡之保存安定性優異之皮膚外用劑。Therefore, it is required to develop an external preparation for skin which is excellent in the use of a liposome, which is different from the above-mentioned technique, and which forms a vesicle excellent in preservation stability, and further requires development of a storage stability of a vesicle even in the presence of an electrolyte. Excellent skin external preparation.

於相關實際情況下,本發明者努力研究的結果,發現含有溶血磷脂質、1種或2種以上選自於25℃為液狀之高級醇或液狀之高級脂肪酸、膽固醇或植物甾醇、及精製水之囊泡係具有優異的保存安定性,完成本發明。In the actual situation, the inventors of the present invention have found that lysophospholipids, one or two or more higher alcohols, liquid or higher fatty acids, cholesterol or phytosterols, which are liquid at 25 ° C, and The vesicles of purified water have excellent preservation stability, and the present invention has been completed.

本發明係提供使含有通常作為親水性乳化劑所使用之溶血磷脂質、1種或2種以上選自於25℃為液狀之高級醇或液狀之高級脂肪酸、膽固醇或植物甾醇、及精製水,新穎且保存安定性優異之囊泡組成物者。The present invention provides a lysophospholipid which is usually used as a hydrophilic emulsifier, one or two or more kinds of higher alcohols, liquid or higher fatty acids, cholesterol or phytosterols selected from liquids at 25 ° C, and refined Water, novel and preserved vesicle composition with excellent stability.

亦即,本發明係關於含有下述成分(a)~(d);That is, the present invention relates to the following components (a) to (d);

(a)溶血磷脂質(a) Lysophospholipids

(b)1種或2種以上選自於25℃為液狀之高級醇或液狀之高級脂肪酸(b) one or more higher alcohols selected from the group consisting of higher alcohols or liquids at 25 ° C

(c)膽固醇或植物甾醇(c) cholesterol or phytosterols

(d)精製水之囊泡組成物。(d) a vesicle composition of purified water.

本發明亦關於更含有成分(e)電解質之上述囊泡組成物。The present invention also relates to the above-described vesicle composition further comprising the component (e) electrolyte.

另外,本發明亦關於成分(b)及成分(c)之含有質量比(b)/(c)為0.2~4之上述囊泡組成物。Further, the present invention also relates to the above-mentioned vesicle composition in which the component (b) and the component (c) have a mass ratio (b)/(c) of 0.2 to 4.

另外,本發明亦關於成分(a)、成分(b)及成分(c)之含有質量比(a)/[(b)+(c)]為0.25~5之上述囊泡組成物。Further, the present invention also relates to the above-mentioned vesicle composition having a mass ratio (a)/[(b)+(c)] of the component (a), the component (b) and the component (c) of 0.25 to 5.

另外,本發明亦關於成分(b)係1種或2種以上選自油醇、異硬脂醇、油酸、異硬脂酸之上述囊泡組成物。Further, in the present invention, the component (b) is one or more selected from the group consisting of oleyl alcohol, isostearyl alcohol, oleic acid, and isostearic acid.

另外,本發明亦關於於25℃時之導電度為0.02~2.5s/m為特徵之上述囊泡組成物。Further, the present invention relates to the above-described vesicle composition characterized by having a conductivity of 0.02 to 2.5 s/m at 25 °C.

另外,就其他觀點,依據本發明,提供含有上述任一種之囊泡組成物之皮膚外用劑。Further, from another viewpoint, according to the present invention, a skin external preparation containing the vesicle composition of any of the above is provided.

本發明之囊泡組成物係保存安定性優異。另外,對肌膚的滲透感高,不發黏的使用感,進而具有保濕效果優異之品質者,本發明之囊泡組成物係有效地作為皮膚外用劑。The vesicle composition of the present invention is excellent in storage stability. In addition, the vesicle composition of the present invention is effective as an external preparation for skin, because it has a high osmotic feeling to the skin, a feeling of not sticky, and further has a quality excellent in moisturizing effect.

[用以實施發明之最佳形態][Best form for implementing the invention]

以下係詳細地說明本發明。另外,本說明書中使用「~」所表示之數值範圍係指包含「~」前後所記載之數值為下限值及上限值之範圍。The invention is described in detail below. In addition, the numerical range represented by "-" in this specification is a range which has the numerical value of the lower-limit and upper-

本發明之囊泡組成物係含有(a)溶血磷脂質。(a)溶血磷脂質係使用為囊泡組成物結構成分。關於該種類並無特別限制。溶血磷脂質之例,包含來自大豆之溶血磷脂質、來自大豆之氫化溶血磷脂質、來自蛋黃溶血磷脂質、來自蛋黃之氫化溶血磷脂質等。此等溶血磷脂質係因應需要,可使用一種、或二種以上。(a)溶血磷脂質係1種酵素改性磷脂質,2位之酯鍵由磷脂酶所水解者。本發明使用之溶血磷脂質係以溶血磷脂質之溶血化率(全磷脂質中之溶血磷脂質之比率)為60%以上,且磷脂膽鹼之純度(以下為「PC純度」)為20%以上者為宜。因為溶血磷脂質之脂肪酸鏈為1條,與脂肪酸鏈為2條之磷脂質相比較,親水性高,及具有與磷脂質相異的化學性質。The vesicle composition of the present invention contains (a) a lysophospholipid. (a) The lysophospholipid system is used as a vesicle composition structural component. There is no particular limitation on this type. Examples of the lysophospholipids include lysophospholipids derived from soybeans, hydrogenated lysophospholipids derived from soybeans, hydrolyzed phospholipids derived from egg yolk, hydrogenated lysophospholipids derived from egg yolk, and the like. These lysophospholipids may be used alone or in combination of two or more. (a) The lysophospholipid is an enzyme-modified phospholipid, and the ester bond at the 2-position is hydrolyzed by a phospholipase. The lysophospholipid used in the present invention has a hemolytic rate of lysophospholipid (the ratio of lysophospholipid in whole phospholipids) of 60% or more, and the purity of phospholipid choline (hereinafter referred to as "PC purity") is 20%. The above is appropriate. Since the lysophospholipid has one fatty acid chain, it has high hydrophilicity and chemical properties different from those of phospholipids compared with two phospholipids having a fatty acid chain.

成分(a)溶血磷脂質之含量雖無特別限定,但以0.01~5質量%(以下單位簡略為「%」)為宜,以0.05~3%尤佳。於此範圍時,可得到保存安定性更優異之囊泡組成物。The content of the component (a) lysophospholipid is not particularly limited, but is preferably 0.01 to 5% by mass (hereinafter simply referred to as "%"), and particularly preferably 0.05 to 3%. In this range, a vesicle composition having more excellent storage stability can be obtained.

另外,亦可同時併用溶血磷脂質及磷脂質。In addition, lysophospholipids and phospholipids can also be used in combination.

本發明之囊泡組成物係含有(b)於25℃為液狀之高級醇或液狀之高級脂肪酸。成分(b)係必須為囊泡結構成分,含有此係可抑制成分(c)之結晶析出,可提升保存安定性。另外,含有成分(b)而可得到對肌膚之滲透感或不發黏之使用感,成為尤其有效地作為皮膚外用劑之囊泡組成物。於25℃為液狀之高級醇之例,包括辛基十二烷醇、油醇、異硬脂醇、異鯨蠟醇、椰子醇、橄欖醇、荷荷芭醇、及癸基十四烷醇;於25℃為液狀之高級脂肪酸之例,包括異硬脂酸、油酸、及亞油酸。可使用此等中之一種或二種以上。其中以油醇、異硬脂醇、油酸、及異硬脂酸為宜。The vesicle composition of the present invention contains (b) a higher alcohol or a liquid higher fatty acid which is liquid at 25 °C. The component (b) must be a vesicle structural component, and the crystallization of the component (c) can be suppressed, and the preservation stability can be improved. In addition, the component (b) contains a feeling of sensation of penetration to the skin or a feeling of not sticking to the skin, and is a vesicle composition which is particularly effective as a skin external preparation. Examples of higher alcohols which are liquid at 25 ° C, including octyldodecanol, oleyl alcohol, isostearyl alcohol, isocetyl alcohol, coconut alcohol, olive alcohol, jojoba alcohol, and mercaptotetradecane Alcohol; an example of a higher fatty acid which is liquid at 25 ° C, including isostearic acid, oleic acid, and linoleic acid. One or more of these may be used. Among them, oleyl alcohol, isostearyl alcohol, oleic acid, and isostearic acid are preferred.

成分(b)之含量雖非特別限定者,但以0.01~5%為宜,以0.05~3%尤佳。若於此範圍時,可得到保存安定性優異之囊泡組成物。The content of the component (b) is not particularly limited, but is preferably 0.01 to 5%, more preferably 0.05 to 3%. When it exists in this range, the vesicle composition which preserves stability is acquired.

本發明之囊泡組成物係含有(c)膽固醇或植物甾醇。(c)膽固醇或植物甾醇係幫助形成囊泡時二分子膜結構之安定性,含有此而可提升保存安定性。The vesicle composition of the present invention contains (c) cholesterol or phytosterol. (c) Cholesterol or phytosterols help to form the stability of the bimolecular membrane structure when vesicles are formed, and this can improve storage stability.

成分(c)之含量雖非特別限定者,但以0.01~5%為宜,以0.05~3%尤佳。若於此範圍時,可得到保存安定性優異之囊泡組成物。The content of the component (c) is not particularly limited, but is preferably 0.01 to 5%, more preferably 0.05 to 3%. When it exists in this range, the vesicle composition which preserves stability is acquired.

本發明之囊泡組成物中,成分(b)與成分(c)之含有質量比(b)/(c)若於0.2~4之範圍時,囊泡之保存安定性將為更加良好者,若於0.5~2時,保存安定性將為進一步更加良好者。另外,本發明之囊泡組成物中,成分(a)、成分(b)與成分(c)之含有質量比(a)/[(b)+(c)]若於0.25~5之範圍時,囊泡之保存安定性將為更加良好者,若於0.4~4之範圍時,保存安定性將為進一步更加良好者。In the vesicle composition of the present invention, when the mass ratio (b)/(c) of the component (b) to the component (c) is in the range of 0.2 to 4, the storage stability of the vesicle is further improved. If it is 0.5 to 2, the preservation stability will be further better. Further, in the vesicle composition of the present invention, the mass ratio (a) / [(b) + (c)] of the component (a), the component (b) and the component (c) is in the range of 0.25 to 5 The preservation stability of the vesicles will be even better. If it is in the range of 0.4 to 4, the preservation stability will be further better.

本發明之囊泡組成物係含有(d)精製水。(d)精製水係作為成分(a)~(c)之分散介質者,係作為含有囊泡之皮膚外用劑之必須成分。該具體之配合量係可依成分(a)~(c)之含量所適當決定,大約50~99%。The vesicle composition of the present invention contains (d) purified water. (d) The purified water is an essential component of the skin external preparation containing vesicles as a dispersion medium of the components (a) to (c). The specific compounding amount can be appropriately determined depending on the contents of the components (a) to (c), and is about 50 to 99%.

本發明之囊泡組成物係藉由親水性之成分(a)、及親油性之成分(b)及成分(c)之親水性-親油性之平衡,於成分(d)中成為二分子膜結構。成分(a)之溶血磷脂質係如所述,因為與通常之磷脂質比較,親水性高,所以不利於形成囊泡。本發明中,藉由使用成分(a)溶血磷脂質、成分(b)液狀之高級醇或液狀之高級脂肪酸、及成分(c)之膽固醇或植物甾醇,補充此點,取得親水性-親油性之平衡,提供安定的囊泡組成物。The vesicle composition of the present invention becomes a bimolecular film in the component (d) by the balance of the hydrophilicity-lipophilicity of the hydrophilic component (a), the lipophilic component (b) and the component (c). structure. The lysophospholipids of the component (a) are as described above, and since they have high hydrophilicity as compared with the usual phospholipids, they are disadvantageous for the formation of vesicles. In the present invention, by using the component (a) lysophospholipid, component (b) liquid higher alcohol or liquid higher fatty acid, and component (c) cholesterol or phytosterol, this is supplemented to obtain hydrophilicity - A balance of lipophilicity provides a stable vesicle composition.

本發明之囊泡組成物係可作為皮膚外用劑使用。此形態係以更含有成分(e)電解質為宜。(e)電解質係配合以賦予保濕效果、消炎效果或美白效果等之目的者。The vesicle composition of the present invention can be used as an external preparation for skin. This form is preferably more containing the component (e) electrolyte. (e) The electrolyte is blended to impart a moisturizing effect, an anti-inflammatory effect, a whitening effect, and the like.

具有保濕效果之電解質例,包含尿素、或胺基酸、乳酸、檸檬酸、吡咯烷酮羧酸等之有機化合物、及此等之鉀、鈉、鎂、鈣等之金屬鹽、氯化鈉、氯化鎂等之無機鹽。Examples of the electrolyte having a moisturizing effect include organic compounds such as urea, or amino acid, lactic acid, citric acid, and pyrrolidone carboxylic acid, and metal salts such as potassium, sodium, magnesium, and calcium, sodium chloride, magnesium chloride, and the like. Inorganic salt.

另外,具有消炎功效之電解質例,包含甘草酸、泛酸等之有機化合物、此等鉀、鈉、鎂、鈣等之金屬鹽等。Further, examples of the electrolyte having an anti-inflammatory effect include organic compounds such as glycyrrhizic acid and pantothenic acid, and metal salts such as potassium, sodium, magnesium, and calcium.

另外,具有美白功效之電解質例,包含抗壞血酸磷酸酯、抗壞血酸烷基酯、抗壞血酸硫酸酯、抗壞血酸葡萄苷等、及此等之鈉、鉀、鎂、鈣等之金屬鹽等之抗壞血酸類。Further, examples of the electrolyte having whitening effect include ascorbic acid such as ascorbyl phosphate, ascorbyl alkyl ester, ascorbyl sulfate, ascorbyl glucoside, and the like, and metal salts such as sodium, potassium, magnesium, and calcium.

另外,亦可舉例如海洋深層水、溫泉水等、含有此等電解質等之來自天然的水溶液。此等係可組合一種或二種以上使用。Further, for example, deep water of the ocean, hot spring water, or the like, a natural aqueous solution containing such an electrolyte or the like may be mentioned. These may be used in combination of one type or two or more types.

此等中,作為皮膚外用劑所使用之形態,(e)電解質係以具有美白效果之水溶性抗壞血酸衍生物、具有保濕效果之乳酸鹽、吡咯烷酮羧酸鹽等為適合例。In the form of the skin external preparation, (e) the electrolyte is a water-soluble ascorbic acid derivative having a whitening effect, a lactate having a moisturizing effect, a pyrrolidone carboxylate or the like, and the like.

另外,上述皮膚外用劑所使用之電解質之具體例係記載於中西紀元及其他「Fragrance Journal」社1995-1 P.71~80;及「化粧品之有效性」藥事日報社P.150。Further, specific examples of the electrolyte used for the external preparation for skin are described in the Western and Western Ages and other "Fragrance Journal" 1995-1 P.71-80; and "The Effectiveness of Cosmetics" Pharmaceutical Daily P.150.

成分(e)之含量雖非特別限定者,但以0.01~10%為宜,以0.1~5%尤佳。若於此範圍時,不損及保存安定性,可得到有效地作為保濕效果、消炎效果、或美白效果優異之皮膚外用劑之囊泡組成物。添加電解質通常會使囊泡不安定化,但因為本發明之囊泡組成物之安定性高,所以作為保濕效果、消炎效果、或美白效果等之藥效成分,即使添加電解質,仍維持良好的安定性。The content of the component (e) is not particularly limited, but is preferably 0.01 to 10%, more preferably 0.1 to 5%. When it is in this range, the vesicle composition which is an external preparation for skin which is effective as a moisturizing effect, an anti-inflammatory effect, or a whitening effect can be obtained without impairing the preservation stability. The addition of the electrolyte usually causes the vesicles to be unstable, but since the vesicle composition of the present invention has high stability, it is maintained as a medicinal component such as a moisturizing effect, an anti-inflammatory effect, or a whitening effect, even if an electrolyte is added. Stability.

本發明之囊泡組成物係除了上述必須成分(a)~(d)以外,亦可含有各種成分。尤其含有多元醇,可得到保存安定性或使用感等更優異之囊泡組成物。作為如此多元醇,雖無特別限制,但於該例中包含丙二醇、1,3-丁二醇、二丙二醇、1,2-戊二醇、甘油、二甘油、山梨糖醇等。其中以1,3-丁二醇、二丙二醇尤佳。The vesicle composition of the present invention may contain various components in addition to the above-mentioned essential components (a) to (d). In particular, a polyhydric alcohol is contained, and a vesicle composition which is more excellent in preservation stability or use feeling can be obtained. The polyhydric alcohol is not particularly limited, but examples thereof include propylene glycol, 1,3-butylene glycol, dipropylene glycol, 1,2-pentanediol, glycerin, diglycerin, and sorbitol. Among them, 1,3-butanediol and dipropylene glycol are particularly preferred.

本發明之囊泡組成物於25℃時之導電度(使用東亞電波工業社製導電度計CM-60G測定)係以0.02~2.5s/m為宜。以0.05~2s/m尤佳。若於此範圍時,不損及囊泡之保存安定性,可充份地發揮(e)電解質之效果,例如保濕效果、消炎效果、或美白效果。The conductivity of the vesicle composition of the present invention at 25 ° C (measured by using a conductivity meter CM-60G manufactured by Toa Denpa Kogyo Co., Ltd.) is preferably 0.02 to 2.5 s/m. It is especially preferable to be 0.05 to 2 s/m. In this range, the effect of the electrolyte (e), such as a moisturizing effect, an anti-inflammatory effect, or a whitening effect, can be sufficiently exerted without impairing the storage stability of the vesicles.

本發明之囊泡組成物係可依各種方法製造。該一例係以溫度80℃程度,使成分(a)及成分(c)溶解於成分(b)之溶液,以及攪拌混合於溫度為80℃程度之成分(d)(因應所需,加熱成分(e),使溶解)後,緩緩冷卻至室溫之方法。The vesicle composition of the present invention can be produced by various methods. This example is a solution in which the component (a) and the component (c) are dissolved in the component (b) at a temperature of about 80 ° C, and the component (d) having a temperature of about 80 ° C is stirred and mixed (the heating component is required ( e) A method of slowly cooling to room temperature after dissolution.

本發明亦關於本發明之含有囊泡組成物之皮膚外用劑。本發明之皮膚外用劑係於不妨礙本發明功效之範圍,可添加通常的皮膚外用劑所配合之任意成分,具體上如成分(b)以外之油劑、醇類、粉體、水溶性高分子、被膜形成劑、界面活性劑、油溶性膠化劑、有機改性黏土礦物、樹脂、紫外線吸收劑、防腐劑、抗菌劑、香料、抗氧化劑、pH調整劑、螯合劑等。The present invention also relates to a skin external preparation containing a vesicle composition of the present invention. The external preparation for skin of the present invention may be added to any of the usual ingredients for external use of the skin, such as an oil agent, an alcohol, a powder, or a water-soluble substance other than the component (b), insofar as it does not impair the efficacy of the present invention. Molecules, film forming agents, surfactants, oil-soluble gelling agents, organically modified clay minerals, resins, ultraviolet absorbers, preservatives, antibacterial agents, perfumes, antioxidants, pH adjusters, chelating agents, and the like.

本發明之皮膚外用劑之用途係可舉例如化粧水、乳液、乳霜、美容液、按摩料、面膜料、護手霜、身體乳霜等之護膚化粧料、化粧用打底化粧料。另外,該使用法係可舉例如以手或手指使用之方法、使不織布含浸而使用之方法等。The use of the external preparation for skin of the present invention may, for example, be a skin care cosmetic such as lotion, lotion, cream, beauty lotion, massage material, facial mask, hand cream, body cream, or makeup primer. Further, the method of use may be, for example, a method of using a hand or a finger, a method of impregnating a nonwoven fabric, or the like.

[實施例][Examples]

以下係舉實施例更詳細地說明本發明,但本發明並非局限於此等者。The invention is illustrated in more detail below by way of examples, but the invention is not limited thereto.

[實施例1][Example 1]

本發明品1~17及比較品1~5:美容液依據下述製法,調製表1~表4所示組成之囊泡組成物。確認囊泡形成係於偏光顯微鏡觀察下進行,由馬耳他十字(Maltese Cross)像的量判斷。Inventive products 1 to 17 and comparative products 1 to 5: cosmetic liquid The vesicle composition of the composition shown in Tables 1 to 4 was prepared according to the following production method. It was confirmed that the vesicle formation was carried out under the observation of a polarizing microscope, and was judged by the amount of the Maltese Cross image.

另外,以此等囊泡組成物作為美容液,塗佈於皮膚,進行評估該使用感及保濕效果。更具體上,由專業調查員對於(1)滲透感、(2)有無發黏、及(3)保濕效果,進行官能評估。合併結果如表1~表4所示。In addition, the vesicle composition is applied to the skin as a cosmetic liquid, and the feeling of use and the moisturizing effect are evaluated. More specifically, the professional investigator performs a functional evaluation on (1) osmotic sensation, (2) presence or absence of stickiness, and (3) moisturizing effect. The combined results are shown in Tables 1 to 4.

(製造方法)(Production method)

A:加熱成分(1)~(9)成80℃。A: The components (1) to (9) were heated to 80 °C.

B:以80℃加熱溶解成分(10)及(11)。B: The components (10) and (11) were dissolved by heating at 80 °C.

C:添加A於B,以分散攪拌機(disper mixer)混合攪拌,形成囊泡。C: A was added to B, and the mixture was stirred and stirred by a disper mixer to form vesicles.

D:將C冷卻至室溫後,添加成分(12)及(13),得到囊泡組成物。D: After cooling C to room temperature, components (12) and (13) were added to obtain a vesicle composition.

(評估方法:囊泡之保存安定性)(Evaluation method: preservation stability of vesicles)

確認囊泡之安定性係於偏光顯微鏡下進行。以囊泡組成物剛調製後之狀態為基準,與40℃恆溫下經過2個月者之狀態進行比較。關於經時觀察所確認之馬耳他十字像的量係使用下述(i)4階段判定基準而判定。It was confirmed that the stability of the vesicles was carried out under a polarizing microscope. The state immediately after the preparation of the vesicle composition was compared with the state of the temperature at 40 ° C for 2 months. The amount of the Maltese cross image confirmed by the observation of time was determined using the following (i) four-stage determination criteria.

(i)4階段判定基準(i) 4-stage decision criteria

(評估方法:使用感及保濕效果)(Evaluation method: use feeling and moisturizing effect)

使20位20~40歲女性調查員使用調製之囊泡組成物作為美容液,關於作為使用感之(1)滲透感、(2)有無發黏、及(3)保濕效果,依據以下(ii)5階段評估基準,進行官能評估,另外,依據(iii)4階段判定基準,判定總調查員評分之平均值。20 female investigators aged 20 to 40 years old used the prepared vesicle composition as a cosmetic liquid, and (1) osmotic feeling, (2) presence or absence of stickiness, and (3) moisturizing effect as a feeling of use, according to the following (ii) A 5-stage evaluation benchmark is used to perform a functional assessment, and an average of the total investigator's score is determined based on the (iii) 4-stage decision criteria.

(ii)5階段評估基準(ii) 5-stage evaluation benchmark

(iii)4階段判定基準(iii) 4-stage decision criteria

(評估方法:導電度)(Evaluation method: conductivity)

使用導電度計(東亞電波工業社製導電度計CM-60G)測定各試料於25℃時之導電度。The conductivity of each sample at 25 ° C was measured using a conductivity meter (conductivity meter CM-60G manufactured by Toa Dentsu Kogyo Co., Ltd.).

由表1~表4之結果顯示,本發明品1~17係於40℃之恆溫下二個月之安定性優異。另外,作為美容液塗佈於皮膚時,為滲透感優異、不發黏之使用感、保濕效果優異者。From the results of Tables 1 to 4, it was revealed that the inventive products 1 to 17 were excellent in stability at a constant temperature of 40 ° C for two months. In addition, when applied to the skin as a beauty liquid, it is excellent in a feeling of penetration, a feeling of use which is not sticky, and an excellent moisturizing effect.

另一方面,不含有成分(a)之比較品1未成形囊泡。另外,不含有成分(b)及成分(c)之比較品2及3、或含有硬脂醇以取代成分(c)之比較品4、含有磷脂質以取代成分(a)之比較品5雖然形成囊泡,但任一種皆於經時觀察時,觀察到膽固醇之結晶析出或沈澱等之保存安定性上有問題。On the other hand, the comparative product 1 which does not contain the component (a) has not formed vesicles. Further, the comparative products 2 and 3 which do not contain the component (b) and the component (c), the comparative product 4 which contains stearyl alcohol in place of the component (c), and the comparative product 5 which contains a phospholipid instead of the component (a) When vesicles were formed, any one of them was observed over time, and it was observed that there was a problem in preservation stability of crystal precipitation or precipitation of cholesterol.

[實施例2:化粧水][Example 2: lotion]

(注3)溶血化率為68%,PC純度為30%。(Note 3) The hemolytic rate was 68%, and the PC purity was 30%.

(製法)(method of law)

A:以80℃加熱溶解成分(1)~(5)。A: The components (1) to (5) were dissolved by heating at 80 °C.

B:加熱成分(6)成80℃。B: The component (6) was heated to 80 °C.

C:添加A於B,於混合攪拌下,使形成囊泡,冷卻至室溫。C: A was added to B, and under agitation, vesicles were formed and cooled to room temperature.

D:添加成分(7)~(12)於C,得到化粧水。D: Adding ingredients (7) to (12) to C to obtain a lotion.

實施例2之化粧水係囊泡之保存安定性良好,滲透感優異、不發黏、保濕效果優異之皮膚外用劑。另外,導電度為0.05s/m。The lotion-based vesicles of Example 2 have excellent storage stability, excellent skin penetration, and are not sticky, and have a moisturizing effect. In addition, the conductivity was 0.05 s/m.

[實施例3:水中油型乳液][Example 3: Oil-in-water emulsion]

(注4)Pemulen TR-2(NOVEON社製)(Note 4) Pemulen TR-2 (made by NOVEON)

(注5)溶血化率為88%,PC純度為80%(Note 5) The hemolytic rate is 88%, and the PC purity is 80%.

(製造方法)(Production method)

A:加熱溶解成分(1)~(7)成70℃。A: The dissolved components (1) to (7) were heated to 70 °C.

B:加熱成分(8)~(12)成70℃後,添加於A,進行乳化。B: After heating the components (8) to (12) to 70 ° C, they were added to A to carry out emulsification.

C:將B冷卻至室溫。C: B was cooled to room temperature.

D:以80℃加熱溶解成分(14)~(18)。D: The components (14) to (18) were dissolved by heating at 80 °C.

E:加熱成分(19)成80℃,添加D下,混合攪拌,形成囊泡。E: The component (19) was heated to 80 ° C, and D was added thereto, followed by mixing and stirring to form vesicles.

F:冷卻E後,添加於C,再添加成分(13),得到水中油型乳液。F: After cooling E, it is added to C, and component (13) is further added to obtain an oily emulsion in water.

實施例3之水中油型乳液係囊泡之保存安定性良好,滲透感優異、不發黏、保濕效果優異之皮膚外用劑。另外,導電度為0.02s/m。The oil-in-water emulsion type vesicles of Example 3 have excellent storage stability, excellent osmotic feeling, and are excellent in skin external preparations which are not sticky and have a moisturizing effect. In addition, the conductivity was 0.02 s/m.

[實施例4:水中油型乳霜][Example 4: Oil-type cream in water]

(製法)(method of law)

A:以70℃加熱溶解成分(1)~(6)。A: The components (1) to (6) were dissolved by heating at 70 °C.

B:以70℃加熱溶解成分(7)、(8)後,添加於A,進行乳化。B: The components (7) and (8) were dissolved by heating at 70 ° C, and then added to A to carry out emulsification.

C:將B冷卻至室溫後,添加成分(9)~(11)。C: After cooling B to room temperature, components (9) to (11) were added.

D:以80℃加熱溶解成分(12)~(15)。D: The components (12) to (15) were dissolved by heating at 80 °C.

E:加熱成分(16)成80℃,添加D下,混合攪拌,形成囊泡。E: The component (16) was heated to 80 ° C, and D was added thereto, followed by mixing and stirring to form vesicles.

F:冷卻E後,添加於C,得到乳霜。F: After cooling E, it is added to C to obtain a cream.

實施例4之水中油型乳霜係囊泡之保存安定性良好,滲透感優異、不發黏、保濕效果優異之皮膚外用劑。另外,導電度為0.07s/m。The oil-in-water cream vesicle of Example 4 is excellent in preservation stability, excellent in osmotic feeling, and non-tacky and moisturizing effect. In addition, the conductivity was 0.07 s/m.

[實施例5:薄片狀化粧料][Example 5: Flaky cosmetic]

(製法)(method of law)

A:以80℃加熱溶解成分(1)~(7)。A: The components (1) to (7) were dissolved by heating at 80 °C.

B:加熱成分(8)成80℃,添加A下,混合攪拌,形成囊泡。B: The component (8) was heated to 80 ° C, and A was added thereto, followed by mixing and stirring to form vesicles.

C:冷卻B後,添加成分(9)~(14),含浸此於不織布。C: After cooling B, components (9) to (14) were added and impregnated into the nonwoven fabric.

D:將C密封填充於鋁層合之袋狀容器,得到薄片狀化粧料。D: The C-sealing was filled in an aluminum laminated bag-shaped container to obtain a sheet-like cosmetic.

實施例5之薄片狀化粗料係囊泡之保存安定性良好,滲透感優異、不發黏、保濕效果優異之皮膚外用劑。另外,導電度為1.18s/m。The flaky crude material vesicles of Example 5 are excellent in storage stability, excellent in osmotic feeling, and non-tacky and moisturizing effect. In addition, the conductivity was 1.18 s/m.

[實施例6:水中油型乳霜狀打底化粧料][Example 6: Oil-based creamy base primer]

(注6)KP-543(丙烯基-聚矽氧烷系接枝共聚物50%:醋酸丁酯50%之混合物,信越化學工業社製)(Note 6) KP-543 (propylene-polyoxyalkylene graft copolymer 50%: 50% butyl acetate mixture, manufactured by Shin-Etsu Chemical Co., Ltd.)

(製造方法)(Production method)

A:以3輥混合機分散處理成分(1)~(5)。A: The components (1) to (5) were dispersed and treated in a 3-roll mixer.

B:均勻混合成分(6)~(11)。B: The components (6) to (11) were uniformly mixed.

C:添加於A於B,進行乳化。C: Added to A at B for emulsification.

D:以80℃加熱溶解成分(12)~(15)。D: The components (12) to (15) were dissolved by heating at 80 °C.

E:加熱成分(16)成80℃,添加D下,混合攪拌,形成囊泡。E: The component (16) was heated to 80 ° C, and D was added thereto, followed by mixing and stirring to form vesicles.

F:冷卻E後,添加於C,得到水中油型乳霜狀打底化粧料。F: After cooling E, it is added to C to obtain an oily creamy base primer in water.

實施例6之水中油型乳霜狀打底化粧料液係囊泡之保存安定性良好,滲透感優異、不發黏、保濕效果優異之皮膚外用劑。另外,導電度為0.13s/m。The oil-in-water cream-like primer liquid of Example 6 is a skin external preparation which is excellent in storage stability, excellent in osmotic feeling, and which is not sticky and has a moisturizing effect. In addition, the conductivity was 0.13 s/m.

Claims (7)

一種囊泡組成物,其特徵為含有下述成分(a)~(d);(a)溶血磷脂質(b)1種或2種以上選自於25℃為液狀之高級醇或液狀之高級脂肪酸(c)膽固醇或植物甾醇(d)精製水,其中,成分(a)之含量為0.01~5質量%,成分(b)之含油量為0.01~5質量%,成分(c)之含油量為0.01~5質量%,成分(b)與成分(c)之含有質量比(b)/(c)為0.2~4及成分(a)、成分(b)與成分(c)之含有質量比(a)/[(b)+(c)]為0.25~5。 A vesicle composition comprising the following components (a) to (d); (a) lysophospholipid (b), one or more selected from the group consisting of higher alcohols or liquids at 25 ° C in liquid form Higher fatty acid (c) cholesterol or phytosterol (d) purified water, wherein the content of the component (a) is 0.01 to 5% by mass, and the oil content of the component (b) is 0.01 to 5% by mass, and the component (c) The oil content is 0.01 to 5% by mass, and the mass ratio (b)/(c) of the component (b) to the component (c) is 0.2 to 4, and the components (a), the components (b), and the component (c) are contained. The mass ratio (a)/[(b)+(c)] is 0.25~5. 如申請專利範圍第1項之囊泡組成物,其中更含有選自1,3-丁二醇、二丙二醇之多元醇。 A vesicle composition according to claim 1 which further comprises a polyhydric alcohol selected from the group consisting of 1,3-butanediol and dipropylene glycol. 如申請專利範圍第1項之囊泡組成物,其中成分(b)係一種或二種以上選自於25℃為液狀之高級醇。 The vesicle composition according to claim 1, wherein the component (b) is one or more selected from the group consisting of higher alcohols which are liquid at 25 ° C. 如申請專利範圍第1項至第3項中任一項之囊泡組成物,其中更含有成分(e)電解質。 The vesicle composition according to any one of claims 1 to 3, which further comprises the component (e) electrolyte. 如申請專利範圍第1項之囊泡組成物,其中成分(b)係1種或2種以上選自油醇、異硬脂醇、油酸、及異硬脂酸。 The vesicle composition of the first aspect of the invention, wherein the component (b) is one or more selected from the group consisting of oleyl alcohol, isostearyl alcohol, oleic acid, and isostearic acid. 如申請專利範圍第1項至第3項中任一項之囊泡 組成物,其於25℃時之導電度為0.02~2.5s/m。 Such as the vesicles of any one of claims 1 to 3 The composition has a conductivity of 0.02 to 2.5 s/m at 25 °C. 一種皮膚外用劑,其特徵係含有申請專利範圍第1項至第3項中任一項之囊泡組成物。 A skin external preparation characterized by comprising the vesicle composition according to any one of claims 1 to 3.
TW097127163A 2007-07-20 2008-07-17 Vesicle composition, and external skin preparations TWI430813B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007190225 2007-07-20

Publications (2)

Publication Number Publication Date
TW200922631A TW200922631A (en) 2009-06-01
TWI430813B true TWI430813B (en) 2014-03-21

Family

ID=40281126

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097127163A TWI430813B (en) 2007-07-20 2008-07-17 Vesicle composition, and external skin preparations

Country Status (6)

Country Link
JP (1) JP5623076B2 (en)
KR (1) KR101492290B1 (en)
CN (1) CN101686911B (en)
HK (1) HK1139601A1 (en)
TW (1) TWI430813B (en)
WO (1) WO2009013864A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5348784B2 (en) 2009-12-28 2013-11-20 株式会社 資生堂 Cosmetics
JP5881139B2 (en) * 2011-03-28 2016-03-09 株式会社 資生堂 Liquid composition and transparent or translucent aqueous composition using the same
EP2692334B1 (en) * 2011-03-31 2015-11-04 Kao Corporation Vesicle composition
JP6139363B2 (en) * 2012-10-02 2017-05-31 株式会社コーセー Cosmetics containing pigments and vesicles
JP6114086B2 (en) * 2013-03-28 2017-04-12 株式会社コーセー Cosmetics
JP6338839B2 (en) * 2013-09-30 2018-06-06 小林製薬株式会社 Emulsified composition
JP6185522B2 (en) * 2014-10-17 2017-08-23 株式会社アスター美容 Non-crystalline composition and external preparation containing the same
US10226442B2 (en) 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0791173B2 (en) * 1986-08-20 1995-10-04 株式会社コーセー Liposomes containing skin cosmetics
JP2636896B2 (en) * 1988-08-24 1997-07-30 キユーピー株式会社 Phospholipid emulsifier
JP4894119B2 (en) * 2001-09-26 2012-03-14 日油株式会社 Fatty acid-containing liposome dispersion
DE10148065A1 (en) * 2001-09-28 2003-04-17 Max Planck Gesellschaft (Ester) -lysolecithins in liposomes
PT1827379E (en) * 2004-10-19 2011-03-23 Max Planck Gesellschaft Formulations containing alkylphosphocholines using novel negative charge carriers

Also Published As

Publication number Publication date
WO2009013864A1 (en) 2009-01-29
CN101686911A (en) 2010-03-31
HK1139601A1 (en) 2010-09-24
KR20100052457A (en) 2010-05-19
JPWO2009013864A1 (en) 2010-09-30
KR101492290B1 (en) 2015-02-11
JP5623076B2 (en) 2014-11-12
CN101686911B (en) 2013-07-03
TW200922631A (en) 2009-06-01

Similar Documents

Publication Publication Date Title
TWI430813B (en) Vesicle composition, and external skin preparations
JP6588568B2 (en) Composition containing bicell structure
KR20090088954A (en) Skin external preparation in the form of water-in-oil emulsion comprising ceramide
JP2008255109A (en) Vesicle composition and external preparation for skin blended with vesicle composition
JP4304352B2 (en) Transdermal absorption control agent containing sophorolipid and method for producing the same
JP2023160936A (en) Composition for stabilizing poorly soluble ingredients and cosmetic composition comprising the same
JP5827079B2 (en) Powder-containing skin external preparation
JP4049216B2 (en) Formulation with liquid crystal structure
JP2005179313A (en) Method for producing base agent for skin cosmetic, and skin cosmetic
JP6959596B2 (en) Topical skin agents and skin barrier function improvers
JP6219029B2 (en) O / W / O emulsifier type skin external preparation
KR20160109869A (en) Emulsified cosmetic composition with acidic pH comprising macro liquid crystal emulsion particle
WO2006057166A1 (en) Cosmetic composition for skin
JP7211818B2 (en) Skin topical agent
JP2016056198A (en) Cosmetic
TW202023525A (en) Hydrogel mask composition, hydrogel mask prepared by using the same and method for preparing the hydrogel mask
TW200916118A (en) External preparation for skin
JP5793056B2 (en) Cosmetics
JP4960004B2 (en) Ubidecalenone-containing cosmetic in vesicle dispersion dosage form
JP2008239523A (en) Solubilized composition by highly blending perfume
KR102594145B1 (en) Nanoemulsion of translucent formulation containing natural ceramide and manufacturing method thereof and manufacturing method of customized cosmetics including the same
KR20190099208A (en) Stick-like skin external solid base material
JP2007277192A5 (en)
JP4082763B2 (en) Emulsified cosmetic
JP2005179320A (en) Oil-in-water emulsified composition